Showing results (241-250 of 5,142) with videos related to
Sort By:
Pageof 515
ACS Chemical Biology|February 18, 2014
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhAHuei-Jiun Li, Cheng-Tsung Lai, Pan Pan, et al.ACS Chemical Biology|February 19, 2014
The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomainsAntje Dittmann, Thilo Werner, Chun-Wa Chung, et al.ACS Chemical Biology|March 1, 2014
MVAPACK: a complete data handling package for NMR metabolomicsBradley Worley, Robert PowersACS Chemical Biology|January 10, 2017
Subcellular Redox Targeting: Bridging in Vitro and in Vivo Chemical BiologyMarcus J C Long, Jesse R Poganik, Souradyuti Ghosh, et al.ACS Chemical Biology|March 14, 2017
Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational AnalysisChris Rechlin, Frithjof Scheer, Felix Terwesten, et al.ACS Chemical Biology|February 16, 2017
Characterization of CYP115 As a Gibberellin 3-Oxidase Indicates That Certain Rhizobia Can Produce Bioactive Gibberellin A4Ryan S Nett, Tiffany Contreras, Reuben J PetersACS Chemical Biology|March 15, 2017
New Ulvan-Degrading Polysaccharide Lyase Family: Structure and Catalytic Mechanism Suggests Convergent Evolution of Active Site ArchitectureThirumalaiSelvi Ulaganathan, Michal T Boniecki, Elizabeth Foran, et al.ACS Chemical Biology|January 28, 2017
Genomics-Guided Exploitation of Lipopeptide Diversity in MyxobacteriaChristian Burgard, Nestor Zaburannyi, Suvd Nadmid, et al.ACS Chemical Biology|January 31, 2017
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye DiseaseJennifer Batson, Hamish D Toop, Clara Redondo, et al.ACS Chemical Biology|January 5, 2017
Chemical Modifications to RNA: A New Layer of Gene Expression RegulationJinghui Song, Chengqi YiPageof 515